Senseonics
Manufacturing · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
20451 Seneca Meadows Pkwy, Germantown, M...Phone Number
(301) 515-7260Website
www.senseonics.comRevenue
$29.3 MillionStock Symbol
SENSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Senseonics
Senseonics Holdings, Inc. is a commercial-stage medical technology company focused on implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its Eversense product line (including Eversense, Eversense XL, Eversense E3, and Eversense 365) uses a long-term undertheskin sensor, a removable rechargeable transmitter, and a mobile app to provide realtime glucose readings and alerts. Senseonics distributes its systems to healthcare providers and patients in the U.S. and internationally through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.Explore more
Senseonics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Senseonics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Senseonics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Senseonics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Senseonics has new funding data
Check out if Senseonics is spiking on competitors!
Product Launch: Get notified when Senseonics launches new products
Earning: See what the market has to say on Senseonics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Senseonics
Senseonics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Senseonics
Compare insights from companies similar to Senseonics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Senseonics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Senseonics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Senseonics.
Senseonics financials insights
Gather financial insights about Senseonics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$20M
Debt
$10M
2016
Stock Offering
$44.8M
Debt
$30M
2017
Stock Offering
$40.4M
2018
Debt
$50M
Stock Offering
$149.5M
2019
Debt
$82M
Stock Offering
$25M
2020
Debt
$12M
2021
Series A
$25.8M
Stock Offering
$115M
Senseonics Tech Stack
A closer look at the technologies used by Senseonics
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Senseonics has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Medical Research
Person-Based
Earnings, Finance
Senseonics News & Media
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performanceSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today highlights two key company events during the 86th Scientific Sessions of the American Diabetes Association (ADA), taking place June 5-8 in New Orleans, Louisiana. Senseonics will be hosting an analyst event to diSenseonics CMO receives RSU and option awards | SENS Insider Trading - Stock Titan
Senseonics Chief Medical Officer Francine Kaufman received 63,177 RSUs and an option on 86,935 shares at $5.54, vesting from mid-2026 through 2030, as equity compensation.Senseonics posts Q1 misses but raises 2026 guidance - Drug Delivery Business
Senseonics (NYSE:SENS) today reported first-quarter financial results that came up shy of Wall Street's expectations.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Senseonics
Sign Up For FreeTo access detailed company insights
Senseonics Holdings, Inc. is a commercial-stage medical technology company focused on implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its Eversense product line (including Eversense, Eversense XL, Eversense E3, and Eversense 365) uses a long-term undertheskin sensor, a removable rechargeable transmitter, and a mobi... Read More
